Achieve Life Sciences Inc [ACHV] stock is trading at $4.84, up 5.45%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ACHV shares have gain 12.04% over the last week, with a monthly amount glided 1.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Achieve Life Sciences Inc [NASDAQ: ACHV] stock has seen the most recent analyst activity on November 25, 2025, when Citizens JMP initiated its Mkt Outperform rating and assigned the stock a price target of $19. Previously, H.C. Wainwright started tracking the stock with Buy rating on August 21, 2025, and set its price target to $12. On November 14, 2024, Rodman & Renshaw initiated with a Buy rating and assigned a price target of $12 on the stock. Raymond James started tracking the stock assigning a Strong Buy rating and suggested a price target of $20 on September 27, 2024. Maxim Group reiterated its recommendation of a Buy and raised its price target to $20 on May 10, 2023. Oppenheimer started tracking with an Outperform rating for this stock on June 23, 2021, and assigned it a price target of $23.
Achieve Life Sciences Inc [ACHV] stock has fluctuated between $1.84 and $5.78 over the past year. Currently, Wall Street analysts expect the stock to reach $4.75 within the next 12 months. Achieve Life Sciences Inc [NASDAQ: ACHV] shares were valued at $4.84 at the most recent close of the market. An investor can expect a potential drop of -1.86% based on the average ACHV price forecast.
Analyzing the ACHV fundamentals
Gross Profit Margin for this corporation currently stands at -0.01% with Operating Profit Margin at -165.12%, Pretax Profit Margin comes in at -229.59%, and Net Profit Margin reading is -229.59%. To continue investigating profitability, this company’s Return on Assets is posted at -1.01, Equity is -1.97 and Total Capital is -0.89. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.49 points at the first support level, and at 4.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.09, and for the 2nd resistance point, it is at 5.34.
Ratios To Look Out For
For context, Achieve Life Sciences Inc’s Current Ratio is 5.14. Also, the Quick Ratio is 5.14, while the Cash Ratio stands at 3.28.
Transactions by insiders
Recent insider trading involved Oki Mark K, Chief Financial Officer, that happened on Sep 18 ’25 when 50060.0 shares were sold. Chief Executive Officer, Stewart Richard Alistair completed a deal on Sep 18 ’25 to sell 0.13 million shares. Meanwhile, Principal Accounting Officer Wan Jerry sold 14070.0 shares on Sep 04 ’25.
